Covid-Vaccine Scientists Begin Plague Jab Trial
Smallpox Therapy Tembexa Approved by FDA
New Ebolavirus Vaccine Design Seeks to Drive Stronger Antibody Defense
African Swine Fever Virus Vaccine Candidate Now Produced in a Cell Line
Researchers Reach New Milestone in the Development of Effective Malaria Vaccine
New Malaria Vaccine Trial Reports 77 Percent Efficacy Rate
Notable Health Seeks to Improve COVID-19 Vaccine Administration through Intelligent Automation
Single-Dose Nipah, Hendra Vaccine for Humans Effective 7 Days after Immunization
How the Ultra-Cold Ebola Vaccine Reached 300,000 People in Africa — and What We Can Learn for COVID
In Crises, Vaccines Can Be Stretched, but Not Easily
Tech Companies Are Racing to Build Smart Vaccine Passports. But Technology Isn't the Only Problem
Combo Monoclonal Antibody Drugs May Lower Coronavirus Loads
Serum Institute: Fire at World's Largest Vaccine Producer Kills Five
ARS Scientists Make Advancements against African Swine Fever Virus
Trojan Horse Antidotes Designed to Neutralize Lethal Botulinum Toxin
INTERPOL Warns of Organized Crime Threat to COVID-19 Vaccines
COVID-Related Shortages of Malarial, Other Drugs Spotlighted
First Large-Scale US Covid-19 Vaccine Trial Reaches Target Enrollment of 30,000 Participants
FDA Approves First Treatment for Ebola Virus
Hepatitis E: The New Challenges of a Peculiar Viral Hepatitis
